Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date

Laura M Wright,1 Matteo De Marco,2 Annalena Venneri2,3 1Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK; 2Department of Life Sciences, Brunel University London, London, UK; 3Department of Medicine and Surgery, University of Parma, Parma, ItalyCorresponden...

Full description

Bibliographic Details
Main Authors: Wright LM, De Marco M, Venneri A
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Psychology Research and Behavior Management
Subjects:
Online Access:https://www.dovepress.com/current-understanding-of-verbal-fluency-in-alzheimers-disease-evidence-peer-reviewed-fulltext-article-PRBM
_version_ 1797831840956940288
author Wright LM
De Marco M
Venneri A
author_facet Wright LM
De Marco M
Venneri A
author_sort Wright LM
collection DOAJ
description Laura M Wright,1 Matteo De Marco,2 Annalena Venneri2,3 1Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK; 2Department of Life Sciences, Brunel University London, London, UK; 3Department of Medicine and Surgery, University of Parma, Parma, ItalyCorrespondence: Annalena Venneri, Email annalena.venneri@brunel.ac.ukAbstract: Since their development, verbal fluency tests (VFTs) have been used extensively throughout research and in clinical settings to assess a variety of cognitive functions in diverse populations. In Alzheimer’s disease (AD), these tasks have proven particularly valuable in identifying the earliest forms of cognitive decline in semantic processing and have been shown to relate specifically to brain regions associated with the initial stages of pathological change. In recent years, researchers have developed more nuanced techniques to evaluate verbal fluency performance, extracting a wide range of cognitive metrics from these simple neuropsychological tests. Such novel techniques allow for a more detailed exploration of the cognitive processes underlying successful task performance beyond the raw test score. The versatility of VFTs and the richness of data they may provide, in light of their low cost and speed of administration, therefore, highlight their potential value both in future research as outcome measures for clinical trials and in a clinical setting as a screening measure for early detection of neurodegenerative diseases.Keywords: fluency, Alzheimer’s disease, AD, semantic, mild cognitive impairment, MCI
first_indexed 2024-04-09T13:58:10Z
format Article
id doaj.art-c15e3fe693034b1dbba172ac5fcf2713
institution Directory Open Access Journal
issn 1179-1578
language English
last_indexed 2024-04-09T13:58:10Z
publishDate 2023-05-01
publisher Dove Medical Press
record_format Article
series Psychology Research and Behavior Management
spelling doaj.art-c15e3fe693034b1dbba172ac5fcf27132023-05-07T16:04:05ZengDove Medical PressPsychology Research and Behavior Management1179-15782023-05-01Volume 161691170583513Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to DateWright LMDe Marco MVenneri ALaura M Wright,1 Matteo De Marco,2 Annalena Venneri2,3 1Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK; 2Department of Life Sciences, Brunel University London, London, UK; 3Department of Medicine and Surgery, University of Parma, Parma, ItalyCorrespondence: Annalena Venneri, Email annalena.venneri@brunel.ac.ukAbstract: Since their development, verbal fluency tests (VFTs) have been used extensively throughout research and in clinical settings to assess a variety of cognitive functions in diverse populations. In Alzheimer’s disease (AD), these tasks have proven particularly valuable in identifying the earliest forms of cognitive decline in semantic processing and have been shown to relate specifically to brain regions associated with the initial stages of pathological change. In recent years, researchers have developed more nuanced techniques to evaluate verbal fluency performance, extracting a wide range of cognitive metrics from these simple neuropsychological tests. Such novel techniques allow for a more detailed exploration of the cognitive processes underlying successful task performance beyond the raw test score. The versatility of VFTs and the richness of data they may provide, in light of their low cost and speed of administration, therefore, highlight their potential value both in future research as outcome measures for clinical trials and in a clinical setting as a screening measure for early detection of neurodegenerative diseases.Keywords: fluency, Alzheimer’s disease, AD, semantic, mild cognitive impairment, MCIhttps://www.dovepress.com/current-understanding-of-verbal-fluency-in-alzheimers-disease-evidence-peer-reviewed-fulltext-article-PRBMfluencyalzheimer’s diseaseadsemanticmild cognitive impairmentmci
spellingShingle Wright LM
De Marco M
Venneri A
Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
Psychology Research and Behavior Management
fluency
alzheimer’s disease
ad
semantic
mild cognitive impairment
mci
title Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
title_full Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
title_fullStr Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
title_full_unstemmed Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
title_short Current Understanding of Verbal Fluency in Alzheimer’s Disease: Evidence to Date
title_sort current understanding of verbal fluency in alzheimer rsquo s disease evidence to date
topic fluency
alzheimer’s disease
ad
semantic
mild cognitive impairment
mci
url https://www.dovepress.com/current-understanding-of-verbal-fluency-in-alzheimers-disease-evidence-peer-reviewed-fulltext-article-PRBM
work_keys_str_mv AT wrightlm currentunderstandingofverbalfluencyinalzheimerrsquosdiseaseevidencetodate
AT demarcom currentunderstandingofverbalfluencyinalzheimerrsquosdiseaseevidencetodate
AT venneria currentunderstandingofverbalfluencyinalzheimerrsquosdiseaseevidencetodate